0001209191-21-004993.txt : 20210122 0001209191-21-004993.hdr.sgml : 20210122 20210122210040 ACCESSION NUMBER: 0001209191-21-004993 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210121 FILED AS OF DATE: 20210122 DATE AS OF CHANGE: 20210122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHERMAN JEFFREY W CENTRAL INDEX KEY: 0001230482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 21547630 MAIL ADDRESS: STREET 1: C/O IDM PHARMA, INC. STREET 2: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-21 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001230482 SHERMAN JEFFREY W C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP and Chief Medical Officer Ordinary Shares 2020-12-29 5 G 0 E 8679 0.00 D 76008 D Ordinary Shares 2020-12-29 5 G 0 E 8679 0.00 A 183634 I By Trust Ordinary Shares 2021-01-21 4 M 0 5353 0.00 A 81361 D Ordinary Shares 2021-01-21 4 F 0 2372 77.43 D 78989 D Performance Restricted Stock Units (PSUs) 2021-01-21 4 M 0 5353 0.00 D Ordinary Shares 5353 5354 D Each PSU represents a contingent right to receive one ordinary share of the Issuer. The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022. /s/ Miles W. McHugh, Attorney-in-Fact 2021-01-22